3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Unknown
2
Sponsor Class
OTHER
2
NIH
1
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Thoracic
1
Breast
1
Conditions
Carcinoma, Non-Small-Cell Lung
153
Lung Neoplasms
73
Pancreatic Neoplasms
44
Neoplasms
27
Neoplasm Metastasis
25
Head and Neck Neoplasms
23
Brain Neoplasms
21
Breast Neoplasms
18
Glioblastoma
15
Adenocarcinoma of Lung
15
Squamous Cell Carcinoma of Head and Neck
14
Gliosarcoma
14
Adenocarcinoma, Bronchiolo-Alveolar
11
Colorectal Neoplasms
10
Glioma
9
Carcinoma, Squamous Cell
8
Carcinoma, Hepatocellular
8
Adenocarcinoma
7
Rectal Neoplasms
6
Prostatic Neoplasms
6
Esophageal Neoplasms
6
Central Nervous System Neoplasms
6
Carcinoma, Renal Cell
6
Astrocytoma
6
Oligodendroglioma
5
Liver Neoplasms
5
Colonic Neoplasms
5
Carcinoma
5
Recurrence
4
Ovarian Neoplasms
4
Interventions
Oxaliplatin
18
Surveys and Questionnaires
15
Fluorouracil
15
Capecitabine
13
Leucovorin
12
Blood Specimen Collection
11
Irinotecan
10
Standard of Care
7
Cisplatin
7
Endoscopic Mucosal Resection
6
atezolizumab
5
Specimen Handling
5
Radiotherapy
5
Educational Status
5
Drug Therapy
5
Docetaxel
5
S 1 (combination)
4
Radiosurgery
4
Nivolumab
4
Magnetic Resonance Spectroscopy
4
Interviews as Topic
4
Gemcitabine
4
Everolimus
4
Colonoscopy
4
Biopsy
4
Bevacizumab
4
tegafur-gimeracil-oteracil
3
pemigatinib
3
apatinib
3
Remote Patient Monitoring
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Gastrointestinal Neoplasms
×
Erlotinib Hydrochloride
×
Clear all
NCT04591431
2023-10-03
ROME
Fondazione per la Medicina Personalizzata
Phase 2
Unknown
400 enrolled
NCT02013089
2016-08-30
GITIC
Sun Yat-sen University
Phase NA
Unknown
50 enrolled